Last Posted: Oct 08, 2019
- Immunotherapy for heart injury
H Stover, Nature Medicine, October 7, 2019 - Programmed Death-Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC.
Ancel Julien et al. Cancers 2019 Sep 11(10) - Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab.
Johansson Peter A et al. Immunogenetics 2019 71(5-6) 433-436 - An updated review of microsatellite instability in the era of next-generation sequencing and precision medicine.
Yamamoto Hiroyuki et al. Seminars in oncology 2019 Sep - Machine-Learning and Stochastic Tumor Growth Models for Predicting Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer.
Siah Kien Wei et al. JCO clinical cancer informatics 2019 Sep 31-11 - Translational Genomics and Recent Advances in Oral Squamous Cell Carcinoma.
Yeeng Chai Annie Wai et al. Seminars in cancer biology 2019 Sep - Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing.
Bonneville Russell et al. Methods in molecular biology (Clifton, N.J.) 2020 2055119-132 - The CRISPR System and Cancer Immunotherapy Biomarkers.
Balan Vitaly et al. Methods in molecular biology (Clifton, N.J.) 2020 2055301-322 - Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
DJ Pinato et al, JAMA Oncology, September 12, 2019 - How Immunotherapy Might Be Used to Treat Heart Failure- Modified immune cells may be trained not just to attack cancer, but any cells in the body that cause disease
G Kolata, NY Times, September 11, 2019
.png)
No hay comentarios:
Publicar un comentario